Midland Wealth Advisors LLC Has $663,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Midland Wealth Advisors LLC reduced its holdings in CVS Health Co. (NYSE:CVS) by 20.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,783 shares of the pharmacy operator’s stock after selling 2,532 shares during the period. Midland Wealth Advisors LLC’s holdings in CVS Health were worth $663,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Whitebox Advisors LLC bought a new stake in CVS Health in the 4th quarter valued at $249,000. B&D White Capital Company LLC acquired a new position in shares of CVS Health during the fourth quarter valued at about $417,000. Fairfax Financial Holdings Ltd. Can acquired a new stake in CVS Health during the fourth quarter worth about $121,742,000. Lazard Asset Management LLC increased its stake in CVS Health by 7.3% during the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator’s stock valued at $192,617,000 after acquiring an additional 293,406 shares during the period. Finally, Seizert Capital Partners LLC raised its holdings in CVS Health by 22.8% in the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator’s stock valued at $25,566,000 after acquiring an additional 105,708 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of CVS stock opened at $63.61 on Monday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51. The stock has a market capitalization of $80.47 billion, a PE ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock’s fifty day moving average is $65.21 and its 200-day moving average is $59.94.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The company’s revenue was up 7.0% on a year-over-year basis. Equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.18%. CVS Health’s dividend payout ratio (DPR) is currently 63.48%.

Analysts Set New Price Targets

CVS has been the subject of a number of recent research reports. UBS Group upped their target price on CVS Health from $67.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, May 2nd. Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Piper Sandler increased their price target on shares of CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a research report on Friday, March 21st. Finally, Robert W. Baird raised their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.